Total Marrow Irradiation with Helical Tomotherapy for Bone Marrow Transplantation of Multiple Myeloma: First Experience in Asia
Three Asian patients with plasma cell myeloma stage IIIa with IgG predominant were selected for autologous hematopoietic cell transplantation (HSCT). Total marrow irradiation (TMI) tomotherapy planned with melphalan 140 mg/m2 as a preconditioning regimen of HSCT. Two image sets of computed tomograph...
Gespeichert in:
Veröffentlicht in: | Technology in cancer research & treatment 2009-02, Vol.8 (1), p.29-37 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 37 |
---|---|
container_issue | 1 |
container_start_page | 29 |
container_title | Technology in cancer research & treatment |
container_volume | 8 |
creator | Shueng, Pei-Wei Lin, Shih-Chiang Chong, Ngot-Swan Lee, Hsing-Yi Tien, Hui-Ju Wu, Le-Jung Chen, Chien-An Lee, Jason J. S. Hsieh, Chen-Hsi |
description | Three Asian patients with plasma cell myeloma stage IIIa with IgG predominant were selected for autologous hematopoietic cell transplantation (HSCT). Total marrow irradiation (TMI) tomotherapy planned with melphalan 140 mg/m2 as a preconditioning regimen of HSCT. Two image sets of computed tomography (CT) were scanned with 2.5 mm and 5 mm for the upper and lower part of the plan, respectively. The junction was determined and marked at 15 cm above knee on both thighs for upper and lower part of the plan. The clinical target volume (CTV) included the entire skeletal system. The planning target volume (PTV) was generated with with 0.8 cm for CTVextremities and with 0.5 cm margin for all other bones of CTV.
A total dose of 800 cGy (200 cGy/fraction) was delivered to the PTV. Update to presentation, all of three patients post transplant without evidence of active disease were noted. During TMI treatment, one with grade 1 vomiting, two with grade 1 nausea, one with grade 1 mucositis, and three with grade 1 anorexia were noted. Toxicity of treatment was scored according to the Common Terminology Criteria for Adverse Events v3.0 (CTCAE v3.0). The average for upper part versus lower part of PTVBone marrow of CI and H-index were 1.5 and 1.4 versus 1.2 and 1.2, respectively. The dose reduction of TMI tomotherapy to various OARs of head, chest, and abdomen relative to TBI varied from 31% to 74%, 21% to 51%, and 46% to 63%, respectively.
The maximum average value of registration for upper torso versus lower extremities in different translation directions were 5.1 mm versus 4.1 mm for pretreatment and 1.5 mm versus 0.7 mm for post-treatment, respectively. The average treatment time for the upper versus lower part in beam-on time, setup time, and MVCT registration time took roughly 49.9, 23.3, and 11.7 min versus 11.5, 10.0, and 7.3 min, respectively. The margin of PTV could be less than 1 cm under good fixation and close position confirmation with MVCT. Antiemetics should be prescribed in the whole course of TMI for emesis prevention. TMI technique replaced TBI technique with 8 Gy as conditioning regiment for multiple myeloma could be acceptable for the Asian and the outcomes were feasible for the Asian. |
doi_str_mv | 10.1177/153303460900800105 |
format | Article |
fullrecord | <record><control><sourceid>sage_AFRWT</sourceid><recordid>TN_cdi_crossref_primary_10_1177_153303460900800105</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_153303460900800105</sage_id><sourcerecordid>10.1177_153303460900800105</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-752c880c6fba37edc311395dfb08b2314bd951624a59e43b77ab48150c9ba0f83</originalsourceid><addsrcrecordid>eNp9kE1PAjEQhhujEUT_gAfTi0dkut1Pb0hASCBe1vNmttuVkt3tpl2CnPzrloB4MHEunbTPM828hNwzeGIsikYs4By4H0ICEAMwCC5I_3A5BM7jy3Pvhz1yY-0GwAtDzq5JjyUsDD0f-uQr1R1WdIXG6B1dGIOFwk7phu5Ut6ZzWSnh3lNd624tDbZ7WmpDX3Qjf6TUYGPbCpvuKOqSrrZVp9rKIXtZ6Rqf6UwZ29HpZyuNko2QVDV0bBXekqsSKyvvTueAvM-m6WQ-XL69Libj5VD4LOiGUeCJOAYRljnySBaCM8aToChziHOPMz8vkoC5lTBIpM_zKMLcj1kAIskRypgPiHecK4y21sgya42q0ewzBtkhzexvmk56OErtNq9l8auc4nPA4wlA62IqXRJC2TPnMYhdJY4bHTmLHzLb6K1p3LL_ff0NrQWK8A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Total Marrow Irradiation with Helical Tomotherapy for Bone Marrow Transplantation of Multiple Myeloma: First Experience in Asia</title><source>Sage Journals GOLD Open Access 2024</source><creator>Shueng, Pei-Wei ; Lin, Shih-Chiang ; Chong, Ngot-Swan ; Lee, Hsing-Yi ; Tien, Hui-Ju ; Wu, Le-Jung ; Chen, Chien-An ; Lee, Jason J. S. ; Hsieh, Chen-Hsi</creator><creatorcontrib>Shueng, Pei-Wei ; Lin, Shih-Chiang ; Chong, Ngot-Swan ; Lee, Hsing-Yi ; Tien, Hui-Ju ; Wu, Le-Jung ; Chen, Chien-An ; Lee, Jason J. S. ; Hsieh, Chen-Hsi</creatorcontrib><description>Three Asian patients with plasma cell myeloma stage IIIa with IgG predominant were selected for autologous hematopoietic cell transplantation (HSCT). Total marrow irradiation (TMI) tomotherapy planned with melphalan 140 mg/m2 as a preconditioning regimen of HSCT. Two image sets of computed tomography (CT) were scanned with 2.5 mm and 5 mm for the upper and lower part of the plan, respectively. The junction was determined and marked at 15 cm above knee on both thighs for upper and lower part of the plan. The clinical target volume (CTV) included the entire skeletal system. The planning target volume (PTV) was generated with with 0.8 cm for CTVextremities and with 0.5 cm margin for all other bones of CTV.
A total dose of 800 cGy (200 cGy/fraction) was delivered to the PTV. Update to presentation, all of three patients post transplant without evidence of active disease were noted. During TMI treatment, one with grade 1 vomiting, two with grade 1 nausea, one with grade 1 mucositis, and three with grade 1 anorexia were noted. Toxicity of treatment was scored according to the Common Terminology Criteria for Adverse Events v3.0 (CTCAE v3.0). The average for upper part versus lower part of PTVBone marrow of CI and H-index were 1.5 and 1.4 versus 1.2 and 1.2, respectively. The dose reduction of TMI tomotherapy to various OARs of head, chest, and abdomen relative to TBI varied from 31% to 74%, 21% to 51%, and 46% to 63%, respectively.
The maximum average value of registration for upper torso versus lower extremities in different translation directions were 5.1 mm versus 4.1 mm for pretreatment and 1.5 mm versus 0.7 mm for post-treatment, respectively. The average treatment time for the upper versus lower part in beam-on time, setup time, and MVCT registration time took roughly 49.9, 23.3, and 11.7 min versus 11.5, 10.0, and 7.3 min, respectively. The margin of PTV could be less than 1 cm under good fixation and close position confirmation with MVCT. Antiemetics should be prescribed in the whole course of TMI for emesis prevention. TMI technique replaced TBI technique with 8 Gy as conditioning regiment for multiple myeloma could be acceptable for the Asian and the outcomes were feasible for the Asian.</description><identifier>ISSN: 1533-0346</identifier><identifier>EISSN: 1533-0338</identifier><identifier>DOI: 10.1177/153303460900800105</identifier><identifier>PMID: 19166240</identifier><identifier>CODEN: TCRTBS</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Biological and medical sciences ; Bone Marrow - radiation effects ; Female ; Hematologic and hematopoietic diseases ; Hematopoietic Stem Cell Transplantation ; Humans ; Immunodeficiencies. Immunoglobulinopathies ; Immunoglobulinopathies ; Immunopathology ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Male ; Medical sciences ; Middle Aged ; Multiple Myeloma - therapy ; Radiotherapy Planning, Computer-Assisted ; Tomography, Spiral Computed - methods ; Transplantation Conditioning ; Whole-Body Irradiation</subject><ispartof>Technology in cancer research & treatment, 2009-02, Vol.8 (1), p.29-37</ispartof><rights>2009 SAGE Publications</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-752c880c6fba37edc311395dfb08b2314bd951624a59e43b77ab48150c9ba0f83</citedby><cites>FETCH-LOGICAL-c415t-752c880c6fba37edc311395dfb08b2314bd951624a59e43b77ab48150c9ba0f83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/153303460900800105$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/153303460900800105$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21947,27832,27903,27904,44924,45312</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1177/153303460900800105?utm_source=summon&utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21088889$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19166240$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shueng, Pei-Wei</creatorcontrib><creatorcontrib>Lin, Shih-Chiang</creatorcontrib><creatorcontrib>Chong, Ngot-Swan</creatorcontrib><creatorcontrib>Lee, Hsing-Yi</creatorcontrib><creatorcontrib>Tien, Hui-Ju</creatorcontrib><creatorcontrib>Wu, Le-Jung</creatorcontrib><creatorcontrib>Chen, Chien-An</creatorcontrib><creatorcontrib>Lee, Jason J. S.</creatorcontrib><creatorcontrib>Hsieh, Chen-Hsi</creatorcontrib><title>Total Marrow Irradiation with Helical Tomotherapy for Bone Marrow Transplantation of Multiple Myeloma: First Experience in Asia</title><title>Technology in cancer research & treatment</title><addtitle>Technol Cancer Res Treat</addtitle><description>Three Asian patients with plasma cell myeloma stage IIIa with IgG predominant were selected for autologous hematopoietic cell transplantation (HSCT). Total marrow irradiation (TMI) tomotherapy planned with melphalan 140 mg/m2 as a preconditioning regimen of HSCT. Two image sets of computed tomography (CT) were scanned with 2.5 mm and 5 mm for the upper and lower part of the plan, respectively. The junction was determined and marked at 15 cm above knee on both thighs for upper and lower part of the plan. The clinical target volume (CTV) included the entire skeletal system. The planning target volume (PTV) was generated with with 0.8 cm for CTVextremities and with 0.5 cm margin for all other bones of CTV.
A total dose of 800 cGy (200 cGy/fraction) was delivered to the PTV. Update to presentation, all of three patients post transplant without evidence of active disease were noted. During TMI treatment, one with grade 1 vomiting, two with grade 1 nausea, one with grade 1 mucositis, and three with grade 1 anorexia were noted. Toxicity of treatment was scored according to the Common Terminology Criteria for Adverse Events v3.0 (CTCAE v3.0). The average for upper part versus lower part of PTVBone marrow of CI and H-index were 1.5 and 1.4 versus 1.2 and 1.2, respectively. The dose reduction of TMI tomotherapy to various OARs of head, chest, and abdomen relative to TBI varied from 31% to 74%, 21% to 51%, and 46% to 63%, respectively.
The maximum average value of registration for upper torso versus lower extremities in different translation directions were 5.1 mm versus 4.1 mm for pretreatment and 1.5 mm versus 0.7 mm for post-treatment, respectively. The average treatment time for the upper versus lower part in beam-on time, setup time, and MVCT registration time took roughly 49.9, 23.3, and 11.7 min versus 11.5, 10.0, and 7.3 min, respectively. The margin of PTV could be less than 1 cm under good fixation and close position confirmation with MVCT. Antiemetics should be prescribed in the whole course of TMI for emesis prevention. TMI technique replaced TBI technique with 8 Gy as conditioning regiment for multiple myeloma could be acceptable for the Asian and the outcomes were feasible for the Asian.</description><subject>Biological and medical sciences</subject><subject>Bone Marrow - radiation effects</subject><subject>Female</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hematopoietic Stem Cell Transplantation</subject><subject>Humans</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multiple Myeloma - therapy</subject><subject>Radiotherapy Planning, Computer-Assisted</subject><subject>Tomography, Spiral Computed - methods</subject><subject>Transplantation Conditioning</subject><subject>Whole-Body Irradiation</subject><issn>1533-0346</issn><issn>1533-0338</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1PAjEQhhujEUT_gAfTi0dkut1Pb0hASCBe1vNmttuVkt3tpl2CnPzrloB4MHEunbTPM828hNwzeGIsikYs4By4H0ICEAMwCC5I_3A5BM7jy3Pvhz1yY-0GwAtDzq5JjyUsDD0f-uQr1R1WdIXG6B1dGIOFwk7phu5Ut6ZzWSnh3lNd624tDbZ7WmpDX3Qjf6TUYGPbCpvuKOqSrrZVp9rKIXtZ6Rqf6UwZ29HpZyuNko2QVDV0bBXekqsSKyvvTueAvM-m6WQ-XL69Libj5VD4LOiGUeCJOAYRljnySBaCM8aToChziHOPMz8vkoC5lTBIpM_zKMLcj1kAIskRypgPiHecK4y21sgya42q0ewzBtkhzexvmk56OErtNq9l8auc4nPA4wlA62IqXRJC2TPnMYhdJY4bHTmLHzLb6K1p3LL_ff0NrQWK8A</recordid><startdate>20090201</startdate><enddate>20090201</enddate><creator>Shueng, Pei-Wei</creator><creator>Lin, Shih-Chiang</creator><creator>Chong, Ngot-Swan</creator><creator>Lee, Hsing-Yi</creator><creator>Tien, Hui-Ju</creator><creator>Wu, Le-Jung</creator><creator>Chen, Chien-An</creator><creator>Lee, Jason J. S.</creator><creator>Hsieh, Chen-Hsi</creator><general>SAGE Publications</general><general>Adenine Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20090201</creationdate><title>Total Marrow Irradiation with Helical Tomotherapy for Bone Marrow Transplantation of Multiple Myeloma: First Experience in Asia</title><author>Shueng, Pei-Wei ; Lin, Shih-Chiang ; Chong, Ngot-Swan ; Lee, Hsing-Yi ; Tien, Hui-Ju ; Wu, Le-Jung ; Chen, Chien-An ; Lee, Jason J. S. ; Hsieh, Chen-Hsi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-752c880c6fba37edc311395dfb08b2314bd951624a59e43b77ab48150c9ba0f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Biological and medical sciences</topic><topic>Bone Marrow - radiation effects</topic><topic>Female</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hematopoietic Stem Cell Transplantation</topic><topic>Humans</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multiple Myeloma - therapy</topic><topic>Radiotherapy Planning, Computer-Assisted</topic><topic>Tomography, Spiral Computed - methods</topic><topic>Transplantation Conditioning</topic><topic>Whole-Body Irradiation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shueng, Pei-Wei</creatorcontrib><creatorcontrib>Lin, Shih-Chiang</creatorcontrib><creatorcontrib>Chong, Ngot-Swan</creatorcontrib><creatorcontrib>Lee, Hsing-Yi</creatorcontrib><creatorcontrib>Tien, Hui-Ju</creatorcontrib><creatorcontrib>Wu, Le-Jung</creatorcontrib><creatorcontrib>Chen, Chien-An</creatorcontrib><creatorcontrib>Lee, Jason J. S.</creatorcontrib><creatorcontrib>Hsieh, Chen-Hsi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Technology in cancer research & treatment</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Shueng, Pei-Wei</au><au>Lin, Shih-Chiang</au><au>Chong, Ngot-Swan</au><au>Lee, Hsing-Yi</au><au>Tien, Hui-Ju</au><au>Wu, Le-Jung</au><au>Chen, Chien-An</au><au>Lee, Jason J. S.</au><au>Hsieh, Chen-Hsi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Total Marrow Irradiation with Helical Tomotherapy for Bone Marrow Transplantation of Multiple Myeloma: First Experience in Asia</atitle><jtitle>Technology in cancer research & treatment</jtitle><addtitle>Technol Cancer Res Treat</addtitle><date>2009-02-01</date><risdate>2009</risdate><volume>8</volume><issue>1</issue><spage>29</spage><epage>37</epage><pages>29-37</pages><issn>1533-0346</issn><eissn>1533-0338</eissn><coden>TCRTBS</coden><abstract>Three Asian patients with plasma cell myeloma stage IIIa with IgG predominant were selected for autologous hematopoietic cell transplantation (HSCT). Total marrow irradiation (TMI) tomotherapy planned with melphalan 140 mg/m2 as a preconditioning regimen of HSCT. Two image sets of computed tomography (CT) were scanned with 2.5 mm and 5 mm for the upper and lower part of the plan, respectively. The junction was determined and marked at 15 cm above knee on both thighs for upper and lower part of the plan. The clinical target volume (CTV) included the entire skeletal system. The planning target volume (PTV) was generated with with 0.8 cm for CTVextremities and with 0.5 cm margin for all other bones of CTV.
A total dose of 800 cGy (200 cGy/fraction) was delivered to the PTV. Update to presentation, all of three patients post transplant without evidence of active disease were noted. During TMI treatment, one with grade 1 vomiting, two with grade 1 nausea, one with grade 1 mucositis, and three with grade 1 anorexia were noted. Toxicity of treatment was scored according to the Common Terminology Criteria for Adverse Events v3.0 (CTCAE v3.0). The average for upper part versus lower part of PTVBone marrow of CI and H-index were 1.5 and 1.4 versus 1.2 and 1.2, respectively. The dose reduction of TMI tomotherapy to various OARs of head, chest, and abdomen relative to TBI varied from 31% to 74%, 21% to 51%, and 46% to 63%, respectively.
The maximum average value of registration for upper torso versus lower extremities in different translation directions were 5.1 mm versus 4.1 mm for pretreatment and 1.5 mm versus 0.7 mm for post-treatment, respectively. The average treatment time for the upper versus lower part in beam-on time, setup time, and MVCT registration time took roughly 49.9, 23.3, and 11.7 min versus 11.5, 10.0, and 7.3 min, respectively. The margin of PTV could be less than 1 cm under good fixation and close position confirmation with MVCT. Antiemetics should be prescribed in the whole course of TMI for emesis prevention. TMI technique replaced TBI technique with 8 Gy as conditioning regiment for multiple myeloma could be acceptable for the Asian and the outcomes were feasible for the Asian.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>19166240</pmid><doi>10.1177/153303460900800105</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | ISSN: 1533-0346 |
ispartof | Technology in cancer research & treatment, 2009-02, Vol.8 (1), p.29-37 |
issn | 1533-0346 1533-0338 |
language | eng |
recordid | cdi_crossref_primary_10_1177_153303460900800105 |
source | Sage Journals GOLD Open Access 2024 |
subjects | Biological and medical sciences Bone Marrow - radiation effects Female Hematologic and hematopoietic diseases Hematopoietic Stem Cell Transplantation Humans Immunodeficiencies. Immunoglobulinopathies Immunoglobulinopathies Immunopathology Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Male Medical sciences Middle Aged Multiple Myeloma - therapy Radiotherapy Planning, Computer-Assisted Tomography, Spiral Computed - methods Transplantation Conditioning Whole-Body Irradiation |
title | Total Marrow Irradiation with Helical Tomotherapy for Bone Marrow Transplantation of Multiple Myeloma: First Experience in Asia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T05%3A55%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sage_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Total%20Marrow%20Irradiation%20with%20Helical%20Tomotherapy%20for%20Bone%20Marrow%20Transplantation%20of%20Multiple%20Myeloma:%20First%20Experience%20in%20Asia&rft.jtitle=Technology%20in%20cancer%20research%20&%20treatment&rft.au=Shueng,%20Pei-Wei&rft.date=2009-02-01&rft.volume=8&rft.issue=1&rft.spage=29&rft.epage=37&rft.pages=29-37&rft.issn=1533-0346&rft.eissn=1533-0338&rft.coden=TCRTBS&rft_id=info:doi/10.1177/153303460900800105&rft_dat=%3Csage_AFRWT%3E10.1177_153303460900800105%3C/sage_AFRWT%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/19166240&rft_sage_id=10.1177_153303460900800105&rfr_iscdi=true |